Lineagen has been providing genetic testing for those with neurodevelopmental disabilities for nearly 10 years. Our focus is on children with autism and delay. We work with physicians and insurance companies to make the testing process easy for families.
Location: United States, Utah, Salt Lake City
Employees: 51-200
Phone: +1 801-931-6200
Total raised: $41.6M
Founded date: 2006
Investors 3
Funding Rounds 3
| Date | Series | Amount | Investors |
| 18.02.2015 | Series C | $15.8M | - |
| 04.01.2011 | Series B | $15M | - |
| 30.08.2010 | Series A | $10.8M | - |
Mentions in press and media 10
| Date | Title | Description |
| 20.01.2023 | Bionano to Host their Virtual Symposium, January 23-26, 2023 | Bionano to Host their Virtual Symposium, January 23-26, 2023 SAN DIEGO (PRWEB) January 20, 2023 Bionano to host their virtual Symposium, from January 23rd to 26th on the Labroots platform. At Bionano’s virtual Symposium, expect to hear from... |
| 18.02.2015 | Lineagen Closes $15.8M Series C Round | SALT LAKE CITY, UT, Innovative molecular diagnostics company focused on disorders of childhood development, announced today the closing of the second and final tranche of its $15.8 million Series C round >> Click here for more fund... |
| 18.02.2015 | Lineagen Closes Second Tranche of $15.8m Series C Financing | Lineagen, Inc., a Salt Lake City, Utah-based molecular diagnostics company focused on disorders of childhood development, closed the second and final tranche of its $15.8m Series C round of financing. In 2013, it had raised the first tranch... |
| 18.12.2013 | Lineagen Raises Financings | Lineagen, Inc., a Salt Lake City, Utah-based molecular diagnostics company focused on complex, genetically linked disorders, completed a $3.5m series C round of financing. The round, which included $2.6m in equity capital and $0.9m in conve... |
| 18.12.2013 | Lineagen Announces $3.5M Series C Round | SALT LAKE CITY, UT, Innovative molecular diagnostics company focused on complex, genetically linked disorders, announced today the Company has completed a $3.5 million series C round of financing. >> Click here for more funding dat... |
| 11.12.2012 | Blood test could diagnose autism spectrum disorders at age 3 | “I think we’re at the beginning of a real revolution in the diagnosis of neurological disorders made with an RNA expression analysis that will really help diagnose neuropsychiatric disorders sooner. An early diagnosis makes it more likely t... |
| 04.01.2011 | Lineagen to Complete $15M Series B Equity Funding Round | Lineagen, Inc., a Salt Lake City, Utah-based provider of diagnostic and healthcare services focused on autism and other complex diseases, for which effective early diagnosis and intervention can have a significant positive impact, is comple... |
| 30.08.2010 | Lineagen Raises $5M from PrairieGold Venture Partners; Closes $10.8M Series A Financing | Lineagen, Inc., a Salt Lake City, Utah-based developer of innovative genomic tests and services for the screening, evaluation and diagnosis of complex disorders and diseases including autism spectrum disorders and others, has received an ad... |
| - | Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. | SAN DIEGO, Aug. 24, 2020 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has acquired Lineagen Inc., a Salt Lake City, Utah based genetic diagnostic company, further supporting our market leadership in digit... |
| - | Blood test could diagnose autism spectrum disorders at age 3 | A blood test under development could indicate whether a toddler has an elevated risk of developing autism spectrum disorder. That could lead to earlier intervention. SynapDx licensed the test from Boston Children’s Hospital last year. It ha... |